<strong>Yaohai Bio-Pharma is China&#39;s first and largest biologics CRDMO (Contract Research, Development and Manufacturing Organization) focusing on microbial expression systems. It provides customized end-to-end solutions from DNA design and synthesis, microbial strain engineering and construction to drug substance manufacturing in GMP or non-GMP level and products fill &amp; finish across diversified modalities, such as recombinant proteins, peptides and polypeptides, enzymes, single domain antibodies (sdAbs), plasmid DNA and mRNA, glyco-polymers, VLPs, to meet global customers&#39; clinical and commercial needs in biological drugs, biosimilars, vaccines and diagnostics for human and veterinary use.</strong>